Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men

NCT01699178 is registered in ClinicalTrials.gov with Clarus Therapeutics, Inc. as lead sponsor.

NCT NCT01699178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01699178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Lead sponsor
Clarus Therapeutics, Inc.
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2012
Completion date
April 30, 2014
Enrollment
182 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

male hypogonadism